The Krüpple-like zinc finger transcription factor, GLI-similar 3 (GLIS3), is critical for pancreatic β cell development and insulin production. Mutations and single nucleotide variants in the GLIS3 gene have been linked to the development of neonatal diabetes and increased risk of type 1 and 2 diabetes. Early during postnatal development pancreatic β cells proliferate and mature; however, little is known about the role of GLIS3 during this stage of β cell development. In this study, we examined the role of GLIS3 on gene expression in β cells during early mouse postnatal development. Immunohistochemistry, QRT-PCR, and transmission electron microscopy indicated that postnatal GLIS3KO islets still contain a large population of β cells that express PDX1, NKX6.1, and ISL-1; however, neonatal insulin production and insulin-secretory granules were greatly reduced in INSlowPDX1+NKX6.1+ cells. Gene expression profiling by RNA-Seq with islets from WT and GLIS3KO mouse and identification of GLIS3 target genes by ChIP-Seq analysis showed that GLIS3 directly regulates the expression of a number of genes involved in β cell function and maturation, including Insulin1 and 2 (Ins1, Ins2), Solute Carrier Family 2 member 2 and 1(Slc2a2, Slc2a1), Activating Transcription Factor 4 and 6b (Atf4, Atf6b), and MAF BZIP Transcription Factor A (MafA), and as well as the expression of a number of metabolic genes. Our study indicates that GLIS3 plays a critical role in the maturation and maintenance of pancreatic β cells during early postnatal development by directly regulating genes with key β cell functions.

Disclosure

H. Kang: None. D. Scoville: None. K. Jeon: None. S. Grimm: None. A.M. Jetten: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.